Aller au contenu principal
Profil bibliographique

Yuki Hamada

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

64Publications signalées
901Citations signalées
4Affiliations récentes

Les institutions déclarées

Les domaines associés

Acute Ischemic Stroke ManagementCerebrovascular and Carotid Artery DiseasesFood Allergy and Anaphylaxis ResearchVirus-based gene therapy researchAllergic Rhinitis and Sensitization

Les publications récentes

Accès ouvert 2025 article OpenAlex

Gut microbial metabolite butyrate boosts p53-expressing telomerase-specific oncolytic adenovirus efficacy by enhancing infectivity and activating MHC-I/cGAS-STING

Masaki Sakamoto, Shinji Kuroda, Tetsuya Katayama, Yu Mikane et autres

The gut microbiota plays an essential role in regulating host immunity, and its metabolites such as butyrate exert immunomodulatory effects by acting as histone deacetylase inhibitors. Oncolytic virotherapy has emerged as a promising approach for cancer treatment, and we have developed OBP-702, …

jp (code pays fourni par la source)

4 citations Cancer Immunology Immunotherapy
Accès ouvert 2025 article OpenAlex

Serum extracellular vesicles containing adenoviral E1A-DNA as a predictive biomarker for liquid biopsy in oncolytic adenovirus therapy

Chiaki Yagi, Shinji Kuroda, Yoshihiko Kakiuchi, Shunya Hanzawa et autres

Oncolytic adenoviruses replicate selectively in tumor cells and induce immunogenic cell death, but predictive biomarkers for early therapeutic response are lacking. This study evaluated extracellular vesicle-encapsulated adenoviral E1A-DNA (EV-E1A-DNA) as a minimally invasive biomarker for monitoring responses to telomerase-specific oncolytic adenoviruses OBP-301 …

jp (code pays fourni par la source)

1 citation Scientific Reports
Accès ouvert 2025 article OpenAlex

The combination of atrial fibrillation and small vessel disease score worsen spontaneous intracerebral hemorrhage outcomes

Yuki Hamada, Takeo Sato, Hideki Matsuoka, Yuka Tsuchimochi et autres

Background This study aimed to examine whether the presence of atrial fibrillation (AF), severity as judged by total small vessel disease (SVD) score, or a combination of these is associated with prognosis and hematoma volume of spontaneous intracerebral hemorrhage (sICH). Methods This …

jp (code pays fourni par la source)

0 citations Frontiers in Neurology
Accès ouvert 2025 article OpenAlex

Pulmonary Cryptococcosis During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR) L858R-Mutant Lung Adenocarcinoma: A Case Report

Yuki Hamada, Toshiaki Motegi, Kenya Kuramoto, Tatsuya Akiyama et autres

Pulmonary cryptococcosis is a rare but important opportunistic fungal infection that may occur during epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer. We describe the case of a woman in her 60s receiving osimertinib for EGFR L858R-mutant lung adenocarcinoma …

jp (code pays fourni par la source)

1 citation Cureus
2025 conference-abstract OpenAlex

Abstract TMP72: Lower High-Density Lipoprotein Cholesterol Level Is Associated With Hematoma Expansion Following Acute Intracerebral Hemorrhage

Takeo Sato, Yuka Tsuchimochi, Yuki Hamada, Yutaro Kawabata et autres

Background&Aims: A certain lipoprotein, especially lower low-density lipoprotein cholesterol (LDL-C), has been said to be a risk of developing intracerebral hemorrhage (ICH). However, the correlation between lipoprotein levels and hematoma expansion (HE) following ICH remains unknown. We aimed to elucidate the relation …

jp (code pays fourni par la source)

0 citations Stroke
Accès ouvert 2024 article OpenAlex

The Vascular Endothelial Growth Factor-A121/Vascular Endothelial Growth Factor-A165 Ratio as a Predictor of the Therapeutic Response to Immune Checkpoint Inhibitors in Gastric Cancer

Yuki Hamada, Kiyonori Tanoue, Takaaki Arigami, Munekazu Yamakuchi et autres

Background/Objectives: The response rate to immune checkpoint inhibitor (ICI) therapy is limited. Further, there is a need to discover biomarkers to predict therapeutic efficacy. The vascular endothelial growth factor (VEGF) is strongly associated with intra-tumoral immunity; however, its utility as a marker …

jp, us (code pays fourni par la source)

3 citations Cancers

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.